15 Facts about HARVONI the recent Hepatitis C from Gilead

15 Facts about HARVONI the recent Hepatitis C from Gilead

HARVONI is a combination of ledipasvir (90mg), a (HCV) NS5A inhibitor, and sofosbuvir (400mg), an HCV nucleotide analog NS5B polymerase inhibitor. HARVONI was approved by FDA on... [[ This is a content summary only. Visit my website for full li...

Close